Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now early-phase tilt small index

Schizophrenia and Related Disorders: early-phase trial registry

5 of 5 indexed Schizophrenia and Related Disorders trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 5 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Schizophrenia and Related Disorders: 5 US clinical trials tracked, 5 recruiting.

Schizophrenia and Related Disorders is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is The University of Texas Health Science Center, Houston, running 2 of these trials.

Enrollment posture brief

Registry condition schizophrenia-and-related-disorders

OPEN 5 | RECR 100% | LATE 0 | EARLY 1 | RANK #3391 | SPON 2

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Schizophrenia and Relate (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Schizophrenia and Related Disorders

Schizophrenia and Related Disorders lists 5 open slots (100% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Schizophrenia and Related Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Schizophrenia and Related Disorders is recruiting above its size-band peers.

    5 of 5 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Schizophrenia and Related Disorders research.

    The University of Texas Health Science Center, Houston accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Schizophrenia and Related Disorders enrolment sits around 120 participants.

    Median target enrolment is 120 among the 5 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.

  4. Schizophrenia and Related Disorders research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Schizophrenia and Related Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Sham rTMS stimulation Device
2 trials
Active rTMS stimulation Device
2 trials
MitoQ Drug
1 trials
SPARK Healthy Sleep Device
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Schizophrenia and Related Disorders trials. A trial with sites in several states counts in each.

Texas 2 trials
Connecticut 2 trials
Massachusetts 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Schizophrenia and Related Disorders page

5 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Schizophrenia and Related Disorders condition card totals 5 registered trials; most-linked intervention Sham rTMS stimulation; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.